Warning: Illegal string offset 'id' in /home/eisai/web/eisai.webx.site/public_html/wp-content/themes/eisai-child/shortcode/sidebar.php on line 8

Eisai (Hong Kong) Co., Ltd

Message from our General Manager

Eisai (Hong Kong) Co., Ltd. is a pharmaceutical company wholly-owned by Eisai Co., Ltd. (Eisai), a Japanese multinational pharmaceutical company headquartered in Tokyo, with strong global R&D capabilities. Eisai (Hong Kong) Co., Ltd. covers both Hong Kong and Macau and has been smoothly developing its business since 1960s.

We promote 13 pharmaceutical brands, in specializing in the fields of Oncology, Central Nervous System, Digestive System, Endocrine and Orthopedics. Global Brands like Aricept® and Pariet® were introduced into the territory at the start of the millennium.

We have a wonderful drug, which through the process of nerve repair is able to help patients overcome symptoms of pain and numbness experienced in diabetes or some orthopedic conditions.

One of our key focus areas is on oncology, where a product has been launched for metastatic breast cancer. We will soon see the debut of another cutting edge product in recurring thyroid cancer. Products for other cancer types namely lung cancer and liver cancer are also in the pipeline.

We recently launched a novel anti-epilepsy drug (AED). It is by far the only AED that is able to show a significant response in heavily treated non-responding epilepsy patients. We will soon launch another AED indicated for Lennox-gastaut syndrome, which is extremely difficult to treat .Our commitment in epilepsy care and management is clearly evident here.
We love our patients and frequently interact with them by way of our hhc (human health care) activities. This year, we spiced it up by having a cooking session with dementia patients as well as having special pricing schemes for breast cancer patients who cannot afford our drug. The hhc notion arises from the belief that the pharma business should not be entirely commercial. We should serve our patients whole-heartedly. Not only do we provide drugs that make them well, but we also care about their general well-being.

We are not a big player in the Hong Kong pharmaceutical market but we will work hard to do everything well, so well that our patients and customers simply love us!

Happy surfing!
Wyeman Tan
General Manager